Skip to content

Does Inclusion of Diaphragmatic Breathing Exercises in Complete Decongestive Therapy Provide Further Benefits in Patients With Breast Cancer Related Lymphedema

Does Inclusion of Diaphragmatic Breathing Exercises in Complete Decongestive Therapy Provide Further Benefits in Patients With Breast Cancer Related Lymphedema

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05754346
Enrollment
40
Registered
2023-03-03
Start date
2023-03-20
Completion date
2023-12-01
Last updated
2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema, Breast Cancer, Lymphedema of Upper Limb

Brief summary

Complete decongestive therapy is proven to be effective in reducing lymphedema related symptoms such as swelling and pain. Breathing exercises, on the other hand, may also help managing lymphedema symptoms. Deep breathing creates a pressure change in the abdomen, which creates a vacuum effect in the thoracic cavity and helps to empty the lymphatic vessels. Thus, we aimed to investigate whether addition of diaphragmatic breathing exercises to physical exercise component of complete decongestive therapy provides further benefits on lymphedema volume, pain and quality of life in patients with breast cancer related lymphedema.

Interventions

Complete Decongestive Therapy will include manual lymphedema drainage (self) for 20 min everyday, skin care everyday, wearing compression garment or bandages everyday and upper-extremity exercises twice a day.

OTHERUpper extremity exercises combined with diaphragmatic breathing exercises

Upper-extremity exercises component of Complete Decongestive Therapy will be performed combined with diaphragmatic breathing exercises.

Sponsors

Bezmialem Vakif University
CollaboratorOTHER
Istanbul Kent University
CollaboratorOTHER
Izmir Bakircay University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of arm lymphedema after being treated for unilateral breast cancer with axillary node dissection * Completion of the treatments for the disease including chemotherapy and radiotherapy after breast surgery

Exclusion criteria

* Having recurrent cancer * Having cognitive disability * Having any concurrent diseases that may interfere with the measurement of lymphedema

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline lymphedema volume at 6th week6 weeksArm volume will be measured using water displacement method.

Secondary

MeasureTime frameDescription
Change from baseline upper extremity pain at 6th week6 weeksVisual analog scale will be used for for quantifying pain.
Change from baseline quality of life at 6th week6 weeksQuality of life will be evaluated using Lymphedema Functioning, Disability and Health Questionnaire for Upper Limb Lymphedema.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026